A spatial model of tumor-host interaction: Application of chemotherapy

In this paper we consider chemotherapy in a spatial model of tumor growth. The model, which is of reaction-diffusion type, takes into account the complex interactions between the tumor and surrounding stromal cells by including densities of endothelial cells and the extra-cellular matrix. When no t...

Full description

Saved in:
Bibliographic Details
Main Authors: Peter Hinow, Philip Gerlee, Lisa J. McCawley, Vito Quaranta, Madalina Ciobanu, Shizhen Wang, Jason M. Graham, Bruce P. Ayati, Jonathan Claridge, Kristin R. Swanson, Mary Loveless, Alexander R. A. Anderson
Format: Article
Language:English
Published: AIMS Press 2009-05-01
Series:Mathematical Biosciences and Engineering
Subjects:
Online Access:https://www.aimspress.com/article/doi/10.3934/mbe.2009.6.521
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832590203239268352
author Peter Hinow
Philip Gerlee
Lisa J. McCawley
Vito Quaranta
Madalina Ciobanu
Shizhen Wang
Jason M. Graham
Bruce P. Ayati
Jonathan Claridge
Kristin R. Swanson
Mary Loveless
Alexander R. A. Anderson
author_facet Peter Hinow
Philip Gerlee
Lisa J. McCawley
Vito Quaranta
Madalina Ciobanu
Shizhen Wang
Jason M. Graham
Bruce P. Ayati
Jonathan Claridge
Kristin R. Swanson
Mary Loveless
Alexander R. A. Anderson
author_sort Peter Hinow
collection DOAJ
description In this paper we consider chemotherapy in a spatial model of tumor growth. The model, which is of reaction-diffusion type, takes into account the complex interactions between the tumor and surrounding stromal cells by including densities of endothelial cells and the extra-cellular matrix. When no treatment is applied the model reproduces the typical dynamics of early tumor growth. The initially avascular tumor reaches a diffusion limited size of the order of millimeters and initiates angiogenesis through the release of vascular endothelial growth factor (VEGF) secreted by hypoxic cells in the core of the tumor. This stimulates endothelial cells to migrate towards the tumor and establishes a nutrient supply sufficient for sustained invasion. To this model we apply cytostatic treatment in the form of a VEGF-inhibitor, which reduces the proliferation and chemotaxis of endothelial cells. This treatment has the capability to reduce tumor mass, but more importantly, we were able to determine that inhibition of endothelial cell proliferation is the more important of the two cellular functions targeted by the drug. Further, we considered the application of a cytotoxic drug that targets proliferating tumor cells. The drug was treated as a diffusible substance entering the tissue from the blood vessels. Our results show that depending on the characteristics of the drug it can either reduce the tumor mass significantly or in fact accelerate the growth rate of the tumor. This result seems to be due to complicated interplay between the stromal and tumor cell types and highlights the importance of considering chemotherapy in a spatial context.
format Article
id doaj-art-9d75fd31f83641a2b2dac2ab6acc0c07
institution Kabale University
issn 1551-0018
language English
publishDate 2009-05-01
publisher AIMS Press
record_format Article
series Mathematical Biosciences and Engineering
spelling doaj-art-9d75fd31f83641a2b2dac2ab6acc0c072025-01-24T01:59:54ZengAIMS PressMathematical Biosciences and Engineering1551-00182009-05-016352154610.3934/mbe.2009.6.521A spatial model of tumor-host interaction: Application of chemotherapyPeter Hinow0Philip Gerlee1Lisa J. McCawley2Vito Quaranta3Madalina Ciobanu4Shizhen Wang5Jason M. Graham6Bruce P. Ayati7Jonathan Claridge8Kristin R. Swanson9Mary Loveless10Alexander R. A. Anderson11Institute for Mathematics and its Applications, University of Minnesota, 114 Lind Hall, Minneapolis, MN 55455Institute for Mathematics and its Applications, University of Minnesota, 114 Lind Hall, Minneapolis, MN 55455Institute for Mathematics and its Applications, University of Minnesota, 114 Lind Hall, Minneapolis, MN 55455Institute for Mathematics and its Applications, University of Minnesota, 114 Lind Hall, Minneapolis, MN 55455Institute for Mathematics and its Applications, University of Minnesota, 114 Lind Hall, Minneapolis, MN 55455Institute for Mathematics and its Applications, University of Minnesota, 114 Lind Hall, Minneapolis, MN 55455Institute for Mathematics and its Applications, University of Minnesota, 114 Lind Hall, Minneapolis, MN 55455Institute for Mathematics and its Applications, University of Minnesota, 114 Lind Hall, Minneapolis, MN 55455Institute for Mathematics and its Applications, University of Minnesota, 114 Lind Hall, Minneapolis, MN 55455Institute for Mathematics and its Applications, University of Minnesota, 114 Lind Hall, Minneapolis, MN 55455Institute for Mathematics and its Applications, University of Minnesota, 114 Lind Hall, Minneapolis, MN 55455Institute for Mathematics and its Applications, University of Minnesota, 114 Lind Hall, Minneapolis, MN 55455In this paper we consider chemotherapy in a spatial model of tumor growth. The model, which is of reaction-diffusion type, takes into account the complex interactions between the tumor and surrounding stromal cells by including densities of endothelial cells and the extra-cellular matrix. When no treatment is applied the model reproduces the typical dynamics of early tumor growth. The initially avascular tumor reaches a diffusion limited size of the order of millimeters and initiates angiogenesis through the release of vascular endothelial growth factor (VEGF) secreted by hypoxic cells in the core of the tumor. This stimulates endothelial cells to migrate towards the tumor and establishes a nutrient supply sufficient for sustained invasion. To this model we apply cytostatic treatment in the form of a VEGF-inhibitor, which reduces the proliferation and chemotaxis of endothelial cells. This treatment has the capability to reduce tumor mass, but more importantly, we were able to determine that inhibition of endothelial cell proliferation is the more important of the two cellular functions targeted by the drug. Further, we considered the application of a cytotoxic drug that targets proliferating tumor cells. The drug was treated as a diffusible substance entering the tissue from the blood vessels. Our results show that depending on the characteristics of the drug it can either reduce the tumor mass significantly or in fact accelerate the growth rate of the tumor. This result seems to be due to complicated interplay between the stromal and tumor cell types and highlights the importance of considering chemotherapy in a spatial context.https://www.aimspress.com/article/doi/10.3934/mbe.2009.6.521tumor invasionanti-angiogenic therapyhypoxiachemotherapymathematical modeling.
spellingShingle Peter Hinow
Philip Gerlee
Lisa J. McCawley
Vito Quaranta
Madalina Ciobanu
Shizhen Wang
Jason M. Graham
Bruce P. Ayati
Jonathan Claridge
Kristin R. Swanson
Mary Loveless
Alexander R. A. Anderson
A spatial model of tumor-host interaction: Application of chemotherapy
Mathematical Biosciences and Engineering
tumor invasion
anti-angiogenic therapy
hypoxia
chemotherapy
mathematical modeling.
title A spatial model of tumor-host interaction: Application of chemotherapy
title_full A spatial model of tumor-host interaction: Application of chemotherapy
title_fullStr A spatial model of tumor-host interaction: Application of chemotherapy
title_full_unstemmed A spatial model of tumor-host interaction: Application of chemotherapy
title_short A spatial model of tumor-host interaction: Application of chemotherapy
title_sort spatial model of tumor host interaction application of chemotherapy
topic tumor invasion
anti-angiogenic therapy
hypoxia
chemotherapy
mathematical modeling.
url https://www.aimspress.com/article/doi/10.3934/mbe.2009.6.521
work_keys_str_mv AT peterhinow aspatialmodeloftumorhostinteractionapplicationofchemotherapy
AT philipgerlee aspatialmodeloftumorhostinteractionapplicationofchemotherapy
AT lisajmccawley aspatialmodeloftumorhostinteractionapplicationofchemotherapy
AT vitoquaranta aspatialmodeloftumorhostinteractionapplicationofchemotherapy
AT madalinaciobanu aspatialmodeloftumorhostinteractionapplicationofchemotherapy
AT shizhenwang aspatialmodeloftumorhostinteractionapplicationofchemotherapy
AT jasonmgraham aspatialmodeloftumorhostinteractionapplicationofchemotherapy
AT brucepayati aspatialmodeloftumorhostinteractionapplicationofchemotherapy
AT jonathanclaridge aspatialmodeloftumorhostinteractionapplicationofchemotherapy
AT kristinrswanson aspatialmodeloftumorhostinteractionapplicationofchemotherapy
AT maryloveless aspatialmodeloftumorhostinteractionapplicationofchemotherapy
AT alexanderraanderson aspatialmodeloftumorhostinteractionapplicationofchemotherapy
AT peterhinow spatialmodeloftumorhostinteractionapplicationofchemotherapy
AT philipgerlee spatialmodeloftumorhostinteractionapplicationofchemotherapy
AT lisajmccawley spatialmodeloftumorhostinteractionapplicationofchemotherapy
AT vitoquaranta spatialmodeloftumorhostinteractionapplicationofchemotherapy
AT madalinaciobanu spatialmodeloftumorhostinteractionapplicationofchemotherapy
AT shizhenwang spatialmodeloftumorhostinteractionapplicationofchemotherapy
AT jasonmgraham spatialmodeloftumorhostinteractionapplicationofchemotherapy
AT brucepayati spatialmodeloftumorhostinteractionapplicationofchemotherapy
AT jonathanclaridge spatialmodeloftumorhostinteractionapplicationofchemotherapy
AT kristinrswanson spatialmodeloftumorhostinteractionapplicationofchemotherapy
AT maryloveless spatialmodeloftumorhostinteractionapplicationofchemotherapy
AT alexanderraanderson spatialmodeloftumorhostinteractionapplicationofchemotherapy